Complement Factor H-ligand interactions: Self-association, multivalency and dissociation constants

Immunobiology

Volumn 217, Issue 2, 2012, Pages 281-297

  Perkins, Stephen J ^a   Nan, Ruodan ^a   Li, Keying ^a   Khan, Sanaullah ^a   Miller, Ami ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Analytical ultracentrifugation; Complement C3; Complement Factor H; Surface plasmon resonance; X ray scattering

Indexed keywords

ALBUMIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BUFFER; C REACTIVE PROTEIN; CALCIUM ION; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; DIMER; HEPARAN SULFATE; HEPARIN DERIVATIVE; LIGAND; MONOMER; OLIGOMER; OLIGOSACCHARIDE; PLASMA PROTEIN; SODIUM CHLORIDE; ZINC;

ALLOTYPE; BINDING SITE; BIOAVAILABILITY; BIOINFORMATICS; BLOOD LEVEL; BLOOD PH; CELL DAMAGE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DIMERIZATION; DISSOCIATION CONSTANT; MASS SPECTROMETRY; MOLECULE; OLIGOMER FORMATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEIN TRANSPORT; RADIATION SCATTERING; REVIEW; SURFACE PLASMON RESONANCE; ULTRACENTRIFUGATION; ZINC BLOOD LEVEL;

C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; COMPLEMENT C3B; COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; HEPARIN; HUMANS; LIGANDS; PROTEIN BINDING; ZINC;

EID: 84855282981     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.10.003     Document Type: Review

References (79)

1. Anderson N.L. Counting the proteins in plasma. Clin. Chem. 2010, 56:1775-1776.
2. Aslam M., Perkins S.J. Folded-back solution structure of monomeric Factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J. Mol. Biol. 2001, 309:1117-1138.
3. Bhattacharjee A., Lehtinen M.J., Kajander T., Goldman A., Jokiranta T.S. Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d. Mol. Immunol. 2010, 47:1686-1691.
4. Blom A.M., Kask L., Ramesh B., Hillarp A. Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H. Arch. Biochem. Biophys. 2003, 418:108-118.
5. 2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor. Anal. Biochem. 2009, 391:39-44.
6. Clark S.J., Higman V.A., Mulloy B., Perkins S.J., Lea S.M., Sim R.B., Day A.J. H384 allotypic variant of factor H associated with age-related macular degeneration has different heparin-binding properties from the non-disease associated form. J. Biol. Chem. 2006, 281:24713-24720.
7. DiScipio R.G. Ultrastructures and interactions of complement factors H and I. J. Immunol. 1992, 149:2592-2599.
8. Dulbecco R., Vogt M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J. Exp. Med. 1954, 99:167-182.
9. Fernando A.N., Furtado P.B., Clark S.J., Gilbert H.E., Day A.J., Sim R.B., Perkins S.J. Associative and structural properties of the region of complement Factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. J. Mol. Biol. 2007, 368:564-581.
10. Fenaille F., Le Mignon M., Groseil C., Ramon C., Riandé S., Siret L., Bihoreau N. Site-specific N-glycan characterization of human complement factor H. Glycobiology 2007, 17:932-944.
11. Forneris F., Ricklin D., Wu J., Tzekou A., Wallace R.S., Lambris J.D., Gros P. Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science 2010, 330:1816-1820.
12. Gabay C., Kushner I. Acute-phase Proteins. eLS 2001.
13. Gilbert H.E., Eaton J.T., Hannan J.P., Holers V.M., Perkins S.J. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study. J. Mol. Biol. 2005, 346:859-873.
14. Good N.E., Winget G.D., Winter W., Connolly T.N., Izawa S., Singh R.M.M. Hydrogen ion buffers for biological research. Biochemistry 1966, 5:467-477.
15. Gros P., Milder F.J., Janssen B.J. Complement driven by conformational changes. Nat. Rev. Immunol. 2008, 8:48-58.
16. Hakobyan S., Harris C.L., Tortajada A., Goicochea de Jorge E., García-Layana A., Fernández-Robredo P., Rodriguez de Córdoba S., Morgan B.P. Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:1983-1990.
17. Hellwage J., Jokiranta T.S., Friese M.A., Wolk T.U., Kampen E., Zipfel P.F., Meri S. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J. Immunol. 2002, 169:6935-6944.
18. Herbert A.P., Uhrín D., Lyon M., Pangburn M.K., Barlow P.N. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. J. Biol. Chem. 2006, 281:16512-16520.
19. Herbert A.P., Deakin J.A., Schmidt C.Q., Blaum B.S., Egan C., Ferreira V.P., Pangburn M.K., Lyon M., Uhrin D., Barlow P.N. Structure shows that a glycosaminoglycan and protein recognition site in Factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J. Biol. Chem. 2007, 282:18960-18968.
20. Hocking H.G., Herbert A.P., Kavanagh D., Soares D.C., Ferreira V.P., Pangburn M.K., Uhrín D., Barlow P.N. Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations. J. Biol. Chem. 2008, 283:9475-9487.
21. Holers V.M. The spectrum of complement alternative pathway-mediated diseases. Immunol. Rev. 2008, 223:300-316.
22. Hurwitz S. Homeostatic control of plasma calcium concentration. Crit. Rev. Biochem. Mol. Biol. 1996, 31:41-100.
23. Janeway C.A., Travers P., Walport M., Schlomchik M.J. Immunobiology: The Immune System in Health and Disease 2005, Garland Science Publishing, New York.
24. Janssen B.J., Huizinga E.G., Raaijmakers H.C., Roos A., Daha M.R., Nilsson-Ekdahl K., Nilsson B., Gros P. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 2005, 437:505-511.
25. Jencks W.P. On the attribution and additivity of binding energies. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:4046-4050.
26. Johnson P.T., Betts K.E., Radeke M.J., Hageman G.S., Anderson D.H., Johnson L.V. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17456-17461.
27. Jokiranta T.S., Hellwage J., Koistinen V., Zipfel P.F., Meri S. Each of the three binding sites of factor H interacts with a distinct site on C3b. J. Biol. Chem. 2000, 275:27657-27662.
28. Jokiranta T.S., Jaakola V.P., Lehtinen M.J., Parepalo M., Meri S., Goldman A. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J. 2006, 25:1784-1794.
29. Kajander T., Lehtinen M.J., Hyvärinen S., Bhattacharjee A., Leung E., Isenman D.E., Meri S., Goldman A., Jokiranta T.S. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2897-2902.
30. Kinoshita C.M., Ying S.C., Hugli T.E., Potempa L.A., Jiang H., Houghten R.A., Gewurz H. Elucidation of a protease sensitive site involved in the binding of calcium to C-reactive protein. Biochemistry 1989, 28:9840-9848.
31. Khan S., Gor J., Mulloy B., Perkins S.J. Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes. J. Mol. Biol. 2010, 395:504-521.
32. Khan S., Rodriguez E., Patel R., Gor J., Mulloy B., Perkins S.J. The solution structure of heparan sulphate differs from that of heparin: implications for function. J. Biol. Chem. 2011, 286:24842-24854.
33. Khan, S., 2011. Solution structures of glycosaminoglycans and their interactions with complement Factor H. PhD thesis, University College London.
34. Lengyel I., Flinn J.M., Peto T., Linkous D.H., Cano K., Bird A.C., Lanzirotti A., Frederickson C.J., van Kuijk F.J.G.M. High concentration of zinc in sub-retinal pigment epithelial deposits. Exp. Eye Res. 2007, 84:772-780.
35. Li K., Okemefuna A.I., Gor J., Hannan J.P., Asokan R., Holers V.M., Perkins S.J. Solution structure of the complex formed between human complement C3d and full length complement receptor Type 2. J. Mol. Biol. 2008, 384:137-150.
36. Li K., Gor J., Perkins S.J. Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3. Biochem. J. 2010, 431:63-72.
37. Li, K., 2010. Interactions of Complement Receptor Type 2 with C3d and Factor H with C3u. PhD Thesis, University College London.
38. Lu J., Stewart A.J., Sadler P.J., Pinheiro T.J., Blindauer C.A. Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem. Soc. Trans. 2008, 36:1317-1321.
39. Law S.K.A., Reid K.B.M. Complement 1995, IRL Press, Oxford. second ed.
40. Morgan H.P., Schmidt C.Q., Guariento M., Blaum B.S., Gillespie D., Herbert A.P., Kavanagh D., Mertens H.D., Svergun D.I., Johansson C.M., Uhrín D., Barlow P.N., Hannan J.P. Structural basis for engagement by complement factor H of C3b on a self surface. Nat. Struct. Mol. Biol. 2011, 18:463-470.
41. Nan R., Gor J., Perkins S.J. Implications of the progressive self-association of wild-type human Factor H for complement regulation and disease. J. Mol. Biol. 2008, 375:891-900.
42. Nan R., Gor J., Lengyel I., Perkins S.J. Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator Factor H and its possible implications for function and disease. J. Mol. Biol. 2008, 384:1341-1352.
43. Nan R., Ward G., Gavigan L., Miller A., Gor J., McKay A.R., Lengyel I., Perkins S.J. The His402 allotype of complement Factor H show similar self-association to the Tyr402 allotype. Mol. Immunol. 2010, 47:2263. (abstract).
44. Nan R., Farabella I., Schumacher F., Miller A., Gor J., Martin A.C.R., Jones D.T., Lengyel I., Perkins S.J. Localisation of the major zinc-binding site of complement Factor H to the SCR-6/8 domains: possible implications for age-related macular degeneration. J. Mol. Biol. 2011, 408:714-735.
45. Nilsson B., Ekdahl K.N. Components of the alternative pathway. The Complement System 1998, 23-49. Springer-Verlag, Berlin. K. Rother, G.O. Till, G.M. Hansch (Eds.).
46. Okemefuna A.I., Gilbert H.E., Griggs K.M., Ormsby R.J., Gordon D.L., Perkins S.J. The regulatory SCR-1/5 and cell-surface-binding SCR-16/20 fragments of Factor H reveal partially folded-back solution structures and different self-associative properties. J. Mol. Biol. 2008, 375:80-101.
47. Okemefuna A.I., Nan R., Gor J., Perkins S.J. Electrostatic interactions contribute to the folded-back conformation of wild-type human Factor H. J. Mol. Biol. 2009, 391:98-118.
48. Okemefuna A.I., Li K., Nan R., Ormsby R.J., Sadlon T., Gordon D.L., Perkins S.J. Multimeric interactions between complement Factor H and its C3d ligand provide new insight on complement regulation. J. Mol. Biol. 2009, 391:119-135.
49. Okemefuna A.I., Stach L., Rana S., Ziai Buetas A.J., Gor J., Perkins S.J. C-reactive protein exists in an NaCl concentration dependent pentamer-decamer equilibrium in physiological buffer. J. Biol. Chem. 2010, 285:1041-1052.
50. Okemefuna A.I., Nan R., Miller A., Gor J., Perkins S.J. Complement Factor H binds at two independent sites to C-reactive protein in acute-phase concentrations. J. Biol. Chem. 2010, 285:1053-1065.
51. Oppermann M., Manuelian T., Jozsi M., Brandt E., Jokiranta T.S., Heinen S., Meri S., Skerka C., Gotze O., Zipfel P.F. The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin. Exp. Immunol. 2006, 144:342-352.
52. Ormsby R.J., Ranganathan S., Tong J.C., Griggs K.M., Dimasi D.P., Hewitt A.W., Burdon K.P., Craig J.E., Hoh J., Gordon D.L. Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:1763-1770.
53. Pangburn M.K., Rawal N., Cortes C., Alam M.N., Ferreira V.P., Atkinson M.A. Polyanion-induced self-association of complement factor H. J. Immunol. 2009, 182:1061-1068.
54. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J. Clin. Invest. 2003, 111:1805-1812.
55. Perkins S.J. Protein volumes and hydration effects: the calculation of partial specific volumes, neutron scattering matchpoints and 280nm absorption coefficients for proteins and glycoproteins from amino acid sequences. Eur. J. Biochem. 1986, 157:169-180.
56. Perkins S.J., Nealis A.S., Sim R.B. Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering. Biochemistry 1991, 30:2847-2857.
57. Perkins S.J., Furtado P.B. Complement and immunoglobulin protein structures by X-ray and neutron solution scattering and analytical ultracentrifugation. Structural Biology of the Complement System 2005, 293-315. Taylor and Francis, Boca Raton, USA. D. Morikis, J.D. Lambris (Eds.).
58. Perkins S.J., Gilbert H.E., Lee Y.C., Sun Z., Furtado P.B. Relating small angle scattering and analytical ultracentrifugation in multidomain proteins. Modern Analytical Ultracentrifugation: Techniques and Methods 2005, 291-319. Royal Society of Chemistry, London, UK, Chapter 15. D.J. Scott, S.E. Harding, A.J. Rowe (Eds.).
59. Perkins S.J., Okemefuna A.I., Fernando A.N., Bonner A., Gilbert H.E., Furtado P.B. Meth. Cell Biol. 2008, 84:375-423.
60. Perkins S.J., Okemefuna A.I., Nan R. Unravelling protein-protein interactions between complement factor H and C-reactive protein by a multidisciplinary strategy. Biochem. Soc. Trans. 2010, 38:894-900.
61. Perkins, S.J., Nan, R., Okemefuna, A.I., Li, K., Khan, S., Miller, A., 2010b. Multiple interactions of complement factor H with its ligands in solution: a progress report. In: Lambris J.D., Adamis A. (Eds.), Current Topics on Complement and Eye Diseases. Adv. Exp. Med. Biol. 703, 25-47.
62. Prosser B.E., Johnson S., Roversi P., Herbert A.P., Blaum B.S., Tyrrell J., Jowitt T.A., Clark S.J., Tarelli E., Uhrin D., Barlow P.N., Sim R.B., Day A.J., Lea S.M. Structural basis for complement factor H - linked age-related macular degeneration. J. Exp. Med. 2007, 204:2277-2283.
63. Putnam F.W. The plasma proteins. Structure, Function and Genetic Control 1975, Academic Press, New York. second ed.
64. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
65. Ripoche J., Day A.J., Harris T.J.R., Sim R.B. The complete amino acid sequence of human factor H. Biochem. J. 1988, 249:593-602.
66. Rodriguez de Cordoba S., Goicoechea de Jorge E. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin. Exp. Immunol. 2008, 151:1-13.
67. Rooijakkers S.H., Wu J., Ruyken M., van Domselaar R., Planken K.L., Tzekou A., Ricklin D., Lambris J.D., Janssen B.J., van Strijp J.A., Gros P. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat. Immunol. 2009, 10:721-727.
68. Saunders R.E., Goodship T.H.J., Zipfel P.F., Perkins S.J. Factor H-associated haemolytic uraemic syndrome: a web database of the structural consequences of disease-associated mutations. Hum. Mutat. 2006, 27:21-30.
69. Schmidt C.Q., Herbert A.P., Kavanagh D., Gandy C., Fenton C.J., Blaum B.S., Lyon M., Uhrín D., Barlow P.N. A new map of glycosaminoglycan and C3b binding sites on factor H. J. Immunol. 2008, 181:2610-2619.
70. Schmidt C.Q., Herbert A.P., Mertens H.D., Guariento M., Soares D.C., Uhrin D., Rowe A.J., Svergun D.I., Barlow P.N. The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module. J. Mol. Biol. 2010, 395:105-122.
71. Schmidt C.Q., Slingsby F.C., Richards A., Barlow P.N. Production of biologically active complement factor H in therapeutically useful quantities. Protein Expr. Purif. 2011, 76:254-263.
72. Sharma A.K., Pangburn M.K. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:10996-11001.
73. Skerka C., Lauer N., Weinberger A.A., Keilhauer C.N., Sühnel J., Smith R., Schlötzer-Schrehardt U., Fritsche L., Heinen S., Hartmann A., Weber B.H., Zipfel P.F. Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol. Immunol. 2007, 44:3398-3406.
74. 1H (factor H). Biochem. J. 1982, 205:285-293.
75. Thompson D., Pepys M.B., Wood S.P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Struct. Fold. Des. 1999, 7:169-177.
76. Walport M.J. Complement. N. Engl. J. Med. 2001, 344:1058-1066. 1140-1144.
77. Wu J., Wu Y.Q., Ricklin D., Janssen B.J., Lambris J.D., Gros P. Structure of complement fragment C3b - factor H and implications for host protection by complement regulators. Nat. Immunol. 2009, 10:728-733.
78. Yu J., Wiita P., Kawaguchi R., Honda J., Jorgensen A., Zhang K., Fischetti V.A., Sun H. Biochemical analysis of a common human polymorphism associated with age-related macular degeneration. Biochemistry 2007, 46:8451-8461.
79. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 2009, 9:729-740.